Healthtech Startups

5 investors

GelSana Therapeutics develops zwitterionic polymer-based biomaterials for wound care, addressing excess sustained inflammation that impedes healing. Its first product, CleraFlex, is a shelf-stable wound dressing designed to reduce inflammation, repel bacteria, balance moisture, and provide a protective barrier.

5 investors

GEM makes whole-food nutritional supplements in the form of plant-based bites designed to address nutrient deficiencies using real food ingredients rather than isolated vitamins. The products are formulated by a team of scientists and doctors using integrative and functional medicine principles, targeting consumers seeking natural wellness solutions.

5 investors

Gennev is a telehealth clinic focused on menopause care, offering video appointments with board-certified, menopause-trained doctors and evidence-based treatment for women from perimenopause through post-menopause. It provides symptom relief, medical questionnaires, and insurance-based payment options.

5 investors

Genoa Healthcare operates full-service pharmacies located inside mental health and community clinics, offering medication management for people with complex needs. It serves consumers with mental health conditions, assisted living residents, and those treating or preventing HIV/AIDS across pharmacies in 48 U.S. states and D.C.

5 investors

Gentem builds a payments platform for medical practices that advances reimbursement on insurance claims rather than making providers wait for payers. It handles claim submission, processing and collection on behalf of clinicians, targeting physicians and small practices that would otherwise carry the administrative burden of revenue cycle work.

5 investors

Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases. It operates a target discovery platform that supports a pipeline of first-in-class assets.

5 investors

Gigasheet processes large healthcare price transparency datasets and uses AI to produce benchmark and market intelligence reports through a spreadsheet-like interface. It serves healthcare providers, self-insured benefits partners, and payers for contract negotiation, network building, and rate benchmarking.

5 investors

Gleamer develops AI copilot software for medical imaging that assists radiologists in detecting pathologies and generating diagnostic reports across X-ray, CT, and MRI modalities. The company serves hospitals and radiology groups with CE and FDA-cleared solutions for fracture detection, chest imaging, bone age assessment, and other diagnostic tasks.

5 investors

GlycanAge offers glycan-based biological age testing and insights to help individuals understand their health and aging rate through advanced diagnostics. The company serves consumers and medical professionals interested in personalized longevity and preventive healthcare.

5 investors

Mars offers personalized science-backed products and services for men's health and wellbeing. The company targets men seeking customized solutions to address their specific health needs.

5 investors

GOQii offers a smart health ecosystem that combines wearable technology and app-based tools with expert human coaching for preventive and value-based care. It serves individuals and organizations, and operates in the US and India.

5 investors

Goryo Chemical develops fluorescence-based technology to visualize diseases and support diagnosis and treatment. The company applies chemistry to medical and healthcare applications for patients and clinicians.

5 investors

Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases. The company operates manufacturing facilities in China and was acquired by AstraZeneca in February 2024.

5 investors

Gradia provides a virtual care platform for patients with chronic conditions, offering integrated communication and specialized care coordination between clinic appointments to supplement traditional in-person care.

5 investors

GraphiteRx operates a marketplace platform that connects pharmacies, hospitals, clinics, and suppliers to streamline healthcare distribution. The company focuses on improving access to healthcare products while reducing costs and complexity in the healthcare supply chain.

5 investors

A clinical hair growth provider offering personalized treatment plans delivered by board-certified medical professionals across multiple locations. The company serves individuals seeking hair restoration and growth solutions through medical expertise in dermatology, aesthetics, and wellness.

5 investors

GroundGame.Health operates a technology platform and hyperlocal operating model that connects health plans, providers, employers, and community-based organizations to address barriers to care and social determinants of health. It coordinates personalized, culturally tailored outreach and leverages a national network of community-based organizations to support individuals in accessing healthcare.

5 investors

Grüns makes nutrient-dense gummy supplements formulated with 60+ whole-food ingredients designed to provide comprehensive daily nutrition. The company targets consumers seeking convenient, portable nutrition alternatives to pills and powders.

5 investors

GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors

5 investors

Hammock provides a platform offering bookkeeping, property tax statements, and real-time financial insights for landlords managing buy-to-let property finances. It serves landlords, letting agents, and property managers in the UK.

5 investors

Hapana provides gym membership management software for fitness studios and gyms, handling scheduling, payments, member engagement, and branded apps. The platform serves boutique fitness and multi-location gym operators.

5 investors

HarmonyCares provides in-home primary care services for vulnerable and complex patients who have difficulty accessing traditional healthcare settings. The company delivers personalized, value-based care focused on improving health equity and outcomes for seniors and other medically complex populations.

5 investors

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease. The biotech company builds a regulatory genome platform to discover tissue- and cell-specific lncRNA targets and turn them into oligonucleotide-based therapies.

5 investors